<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2002000100001</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Serogrupos, serosubtipos, inmunotipos y susceptibilidad antimicrobiana de cepas de Neisseria meningitidis aisladas de portadores]]></article-title>
<article-title xml:lang="en"><![CDATA[Serogroups, serosubtypes, inmunotypes ansusceptibility antimicrobian of Neisseria meningitidis strains isolated from carriers]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zamora]]></surname>
<given-names><![CDATA[Leydis]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[Niuris]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ginebra]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Climent]]></surname>
<given-names><![CDATA[Yanet]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[Franklin]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camaraza]]></surname>
<given-names><![CDATA[María Amalia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Finlay  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2002</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2002</year>
</pub-date>
<volume>11</volume>
<numero>1</numero>
<fpage>1</fpage>
<lpage>4</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2002000100001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2002000100001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2002000100001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Teniendo en cuenta el papel fundamental que desempeñan los portadores asintomáticos de Neisseria meningitidis en la transmisión de la enfermedad meningocócica, se hace necesario profundizar en los aspectos relacionados con la caracterización fenotípica de este microorganismo. Con el propósito de contribuir a la identificación de cepas circulantes actualmente en nuestro país, se clasificaron 32 cepas de N. meningitidis aisladas en estudiantes del politécnico de oficios electromecánicos &#8220;Rodolfo Ramírez Esquivel&#8221;, de la provincia de Ciego de Avila. La identificación en género, especie y serogrupos, se realizó por métodos convencionales y para la clasificación en serosubtipos e inmunotipos se empleó un ELISA de células enteras con AcM. Se estudió la susceptibilidad antimicrobiana mediante el método de dilución en agar, determinando las concentraciones mínimas inhibitorias (CMI) de la penicilina, cloranfenicol, ciprofloxcina, sulfonamida, rifampicina y ceftriaxona.Predominaron las cepas NA:NT:P1.NST:L3,7,9 (22,8%), el 82% de las cepas fue resistente a la sulfonamida y el 13% mostró sensibilidad disminuida a la penicilina]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Considering the fundamental role played by asymptomatic Neisseria meningitidis carriers in the transmission of the meningococcal disease, it is necessary to study the issues related to the phenotypical characterization of this microorganism more deeply. With the purpose of contributing to the identification of the strains present circulating in our country, 32 strains of N. meningitidis isolated in students from a Polytechnical Institute in the Province of Ciego de Avila were classified. The identification by genus, species and serogroups was carried out by conventional methods and for the classification into sero/subtypes and immunotypes a whole-cell ELISA with Mabs was used. The antimicrobial susceptibility was studied by the agar dilution method, determining the MIC for penicillin, cloramphenicol, ciprofloxacine, sulfonamide, rifampicine and ceftriaxone. The NA:NT:P1.NST:L3,7,9 strains predominated at (22,8%). An 82% of the strains was sulfonamide resistant, and 13% showed decreased sensitivity to penicillin]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Serogrupos]]></kwd>
<kwd lng="es"><![CDATA[serotipos]]></kwd>
<kwd lng="es"><![CDATA[subtipos]]></kwd>
<kwd lng="es"><![CDATA[inmunotipos]]></kwd>
<kwd lng="es"><![CDATA[susceptibilidad]]></kwd>
<kwd lng="en"><![CDATA[Serogroups]]></kwd>
<kwd lng="en"><![CDATA[serotypes]]></kwd>
<kwd lng="en"><![CDATA[subtypes]]></kwd>
<kwd lng="en"><![CDATA[immunotypes]]></kwd>
<kwd lng="en"><![CDATA[suceptibility]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana" size="2"><b>ARTICULOS ORIGINALES</b></font></p>     <p align="right">&nbsp;</p>     <p align="right"><font size="2" face="Verdana"><strong><font size="4">Serogrupos, serosubtipos, inmunotipos y    susceptibilidad antimicrobiana de cepas de Neisseria    meningitidis aisladas de portadores</font>.    <br> </strong></font></p>     <p align="right">&nbsp;</p>     <p align="right"><strong><font size="3" face="Verdana">Serogroups, serosubtypes, inmunotypes ansusceptibility antimicrobian of Neisseria meningitidis strains isolated from carriers.</font></strong></p>     <p align="justify">&nbsp;</p>     <p align="justify"><strong><font size="2" face="Verdana">Leydis Zamora, Isabel Mart&iacute;nez, Mercedes Guti&eacute;rrez, Niuris N&uacute;&ntilde;ez, M&oacute;nica Ginebra, Yanet Climent,     Franklin Sotolongo, Mar&iacute;a Amalia Camaraza.</font></strong></p>     <p align="justify">&nbsp;</p>     <p align="justify"><font size="2" face="Verdana">Instituto Finlay. Centro de Investigaci&oacute;n-Producci&oacute;n de Vacunas y Sueros. Ciudad de La Habana, Cuba.     E-mail: <a href="emailto:lzamora@finlay.edu.cu">lzamora@finlay.edu.cu</a>    ]]></body>
<body><![CDATA[<br> </font></p> <hr align="JUSTIFY">     <p align="justify"><font face="Verdana, Arial, Helvetica, sans-serif"><strong><font size="2">RESUMEN</font></strong></font></p>     <p align="justify"><font size="2" face="Verdana">Teniendo en cuenta el papel fundamental que desempe&ntilde;an los portadores asintom&aacute;ticos de Neisseria    meningitidis en la transmisi&oacute;n de la enfermedad meningoc&oacute;cica, se hace necesario profundizar en los    aspectos relacionados con la caracterizaci&oacute;n fenot&iacute;pica de este microorganismo. Con el prop&oacute;sito de    contribuir a la identificaci&oacute;n de cepas circulantes actualmente en nuestro pa&iacute;s, se clasificaron 32    cepas de N. meningitidis aisladas en estudiantes del polit&eacute;cnico de oficios electromec&aacute;nicos &ldquo;Rodolfo    Ram&iacute;rez Esquivel&rdquo;, de la provincia de Ciego de Avila. La identificaci&oacute;n en g&eacute;nero, especie y    serogrupos, se realiz&oacute; por m&eacute;todos convencionales y para la clasificaci&oacute;n en serosubtipos e    inmunotipos se emple&oacute; un ELISA de c&eacute;lulas enteras con AcM. Se estudi&oacute; la susceptibilidad    antimicrobiana mediante el m&eacute;todo de diluci&oacute;n en agar, determinando las concentraciones m&iacute;nimas    inhibitorias (CMI) de la penicilina, cloranfenicol, ciprofloxcina, sulfonamida, rifampicina y ceftriaxona.Predominaron las cepas NA:NT:P1.NST:L3,7,9 (22,8%), el 82% de las cepas fue resistente a la    sulfonamida y el 13% mostr&oacute; sensibilidad disminuida a la penicilina.    <br>   </font></p>     <p align="justify"><font size="2" face="Verdana"><strong>Palabras claves:</strong> Serogrupos, serotipos, subtipos, inmunotipos, susceptibilidad.</font></p> <hr align="JUSTIFY">     <p align="justify"><font size="2" face="Verdana">  <strong>ABSTRACT</strong></font></p>     <p align="justify"><font size="2" face="Verdana">    <br>   Considering the fundamental role played by asymptomatic Neisseria meningitidis carriers in the transmission of    <br>   the meningococcal disease, it is necessary to study the issues related to the phenotypical characterization of    <br>   this microorganism more deeply. With the purpose of contributing to the identification of the strains present    ]]></body>
<body><![CDATA[<br>   circulating in our country, 32 strains of N. meningitidis isolated in students from a Polytechnical Institute in the    <br>   Province of Ciego de Avila were classified. The identification by genus, species and serogroups was carried    <br>   out by conventional methods and for the classification into sero/subtypes and immunotypes a whole-cell ELISA    <br>   with Mabs was used. The antimicrobial susceptibility was studied by the agar dilution method, determining the    <br>   MIC for penicillin, cloramphenicol, ciprofloxacine, sulfonamide, rifampicine and ceftriaxone. The    <br>   NA:NT:P1.NST:L3,7,9 strains predominated at (22,8%). An 82% of the strains was sulfonamide resistant, and    <br>   13% showed decreased sensitivity to penicillin.    <br>   </font></p>     <p align="justify"><font size="2" face="Verdana"><strong>Keywords:</strong> Serogroups, serotypes, subtypes, immunotypes, suceptibility</font></p> <hr align="JUSTIFY">     <p align="justify">Texto completo en pdf </p>     ]]></body>
<body><![CDATA[<P  ALIGN="JUSTIFY"><font face="Verdana, Arial, Helvetica, sans-serif"><font size="2"><strong>Referencias</strong></font>  </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Gotschlich EC. Meningococcal meningitis. In: Bacterial Vaccines. New york. Ed. R. Germanier; 1990: 237-255. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Broome CV. The carrier state: Neisseria meningitidis.J Antimicrob Chemother 1986; 18 (Suppl A): 25-34. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. P&eacute;rez CA, P&eacute;rez AMC, S&aacute;ez-Nieto JA. Genetic transformation of penicillin susceptible. Neisseria meningitidis with Neisseria perflava/sicca moderately resistant to penicillin and pen A gene sequences of transformantes. Rev Esp Quimiot 1997. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Sotolongo F, Patton AS, Mart&iacute;nez I, Sampedro MC, Marberty JA, Garc&iacute;a AM et al. Neisseria meningitidis. Aspectos te&oacute;rico - pr&aacute;cticos sobre el diagn&oacute;stico, clasificaci&oacute;n y valoraci&oacute;n de la respuesta inmune. 3era. ed. La Habana: Ediciones Finlay; 1994. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Abdillahi H, Poolman JT. Whole cells ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Letters 1987; 48:367-371. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. NCCLS. National Committee fro Clinical Laboratory Standard. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. American National Standards Institute 1999. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Valcarcel NM. Prevalencia de Neisseria meningitidis en portadores escolares y ni&ntilde;os de c&iacute;rculos infantiles del municipio Artemisa.[Trabajo para optar por el t&iacute;tulo de Especialista de 1er grado en Epidemiolog&iacute;a]. Ciudad de La Habana. 1979. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Valc&aacute;rcel M, Rodr&iacute;guez R, Terry H. La Enfermedad Meningoc&oacute;cica en Cuba. Cronolog&iacute;a de una Epidemia. 1ra ed. Ciudad de La Habana: Editorial Ciencias M&eacute;dicas de Cuba; 1991:319-397. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Fern&aacute;ndez CJA. Cin&eacute;tica de la actividad bactericida s&eacute;rica y los isotipos IgA e IgM estimulados por los componentes inmunog&eacute;nicos de la vacuna meningoc&oacute;cica VA-MENGOC-BC&#174;.[Trabajo de Terminaci&oacute;n de residencia en Inmunolog&iacute;a]. Ciudad de La Habana; 1994. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Mart&iacute;nez I, Matute I, Guti&eacute;rrez M, N&uacute;&ntilde;ez N, Sotolongo F, Garc&iacute;a D, et al. Ensayo de un dise&ntilde;o metodol&oacute;gico para la b&uacute;squeda de portadores de Neisseria meningitidis. VacciMonitor. 1999; 8(12):2-9. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Caro E, Mart&iacute;nez I, Guti&eacute;rrez M, N&uacute;&ntilde;ez N, Rodr&iacute;guez L, Sotolongo F, et al. Marcadores epidemiol&oacute;gicos de cepas de Neisseria meningitidis aisladas en Cuba durante el per&iacute;odo 1985-1992. VacciMonitor 2000;9(1):5-11. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Acanda Pozo ME. Adherencia de Neisseria meningitidis a c&eacute;lulas epiteliales [Trabajo para optar por el t&iacute;tulo de M&aacute;ster en Microbiolog&iacute;a. Perfil Bacteriolog&iacute;a-Micolog&iacute;a]. Ciudad de La Habana; 1997. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Sholten RJPM. Lipoolygosaccharide inmunotyping of Neisseria meningitidis by whole cell ELISA with monoclonal antibodies. J Med Microbiol 1994; 41 (4): 236-243. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Mart&iacute;nez I, Garc&iacute;a D, Sotolongo F, Guti&eacute;rrez M, Matute I, Nu&ntilde;ez N, et al. Susceptibilidad a agentes antimicrobianos de cepas de Neisseria meningitidis aisladas en portadores. VacciMonitor 2000; 9(2):7-13 </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Blondeau JM, Ashton M, Isaacson Y, Anderson C, Ducasse G. Neisseria meningitidis with decreaaased susceptibility to penicillin in Saskatchewan, Canada.      J. Clin. Microbiol. 1995; 33:1784-1786. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Palmeiro S, Almiron M, Regueira M. Prevalencia de sero/subtipos de Neisseria meningitidis en Argentina entre 1994-1995. XIII Congreso Latinoamericano de Microbiolog&iacute;a. Buenos aires, Argentina. 1996:212-213. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Gaunt PN, Lambert BE. Single dose ciprofloxacin for the erradication of pharyngeal carriage of Neisseria meningitidis. J. Antimicrob Chemother 1988; 21:489-496.</font>     ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gotschlich]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Meningococcal meningitis]]></article-title>
<source><![CDATA[Bacterial Vaccines]]></source>
<year>1990</year>
<page-range>237-255</page-range><publisher-loc><![CDATA[New york ]]></publisher-loc>
<publisher-name><![CDATA[R. Germanier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Broome]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The carrier state: Neisseria meningitidis]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>1986</year>
<volume>18</volume>
<numero>^sA</numero>
<issue>^sA</issue>
<supplement>A</supplement>
<page-range>25-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[AMC]]></given-names>
</name>
<name>
<surname><![CDATA[Sáez-Nieto]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Genetic transformation of penicillin susceptible Neisseria meningitidis with Neisseria perflava/sicca moderately resistant to penicillin and pen A gene sequences of transformantes]]></article-title>
<source><![CDATA[Rev Esp Quimiot]]></source>
<year>1997</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Patton]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sampedro]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Marberty]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<source><![CDATA[Neisseria meningitidis: Aspectos teórico- prácticos sobre el diagnóstico, clasificación y valoración de la respuesta inmune]]></source>
<year>1994</year>
<edition>3era</edition>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Finlay]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abdillahi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Poolman]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Whole cells ELISA for typing Neisseria meningitidis with monoclonal antibodies]]></article-title>
<source><![CDATA[FEMS Microbiol Letters.]]></source>
<year>1987</year>
<volume>48</volume>
<page-range>367-371</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>CCLS</collab>
<source><![CDATA[Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically]]></source>
<year>1999</year>
<publisher-name><![CDATA[American National Standards Institute.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valcarcel]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de Neisseria meningitidis en portadores escolares y niños de círculos infantiles del municipio Artemisa]]></source>
<year></year>
<conf-name><![CDATA[ Trabajo para optar por el título de Especialista de 1er grado en Epidemiología.]]></conf-name>
<conf-date>1979</conf-date>
<conf-loc>Ciudad de La Habana </conf-loc>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valcárcel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Terry]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[La Enfermedad Meningocócica en Cuba: Cronología de una Epidemia]]></source>
<year>1991</year>
<edition>1ra</edition>
<page-range>319-397</page-range><publisher-loc><![CDATA[Ciudad de La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ciencias Médicas de Cuba]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[CJA]]></given-names>
</name>
</person-group>
<source><![CDATA[Cinética de la actividad bactericida sérica y los isotipos IgA e IgM estimulados por los componentes inmunogénicos de la vacuna meningocócica VA-MENGOC-BC®]]></source>
<year>1994</year>
<conf-name><![CDATA[ Trabajo de Terminación de residencia en Inmunología]]></conf-name>
<conf-loc>Ciudad de La Habana </conf-loc>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Matute]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[et]]></surname>
<given-names><![CDATA[al]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Ensayo de un diseño metodológico para la búsqueda de portadores de Neisseria meningitidis]]></article-title>
<source><![CDATA[VacciMonitor.]]></source>
<year>1999</year>
<volume>8</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[et]]></surname>
<given-names><![CDATA[al]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Marcadores epidemiológicos de cepas de Neisseria meningitidis aisladas en Cuba durante el período 1985-1992]]></article-title>
<source><![CDATA[VacciMonitor.]]></source>
<year>2000</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5-11</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acanda Pozo]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<source><![CDATA[Adherencia de Neisseria meningitidis a células epiteliales]]></source>
<year>1997</year>
<conf-name><![CDATA[ Trabajo para optar por el título de Máster en Microbiología. Perfil Bacteriología-Micología]]></conf-name>
<conf-loc>Ciudad de La Habana </conf-loc>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sholten]]></surname>
<given-names><![CDATA[RJPM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Lipoolygosaccharide inmunotyping of Neisseria meningitidis by whole cell ELISA with monoclonal antibodies]]></article-title>
<source><![CDATA[J Med Microbiol.]]></source>
<year>1994</year>
<volume>41</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>236-243</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Matute]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[et]]></surname>
<given-names><![CDATA[al]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Susceptibilidad a agentes antimicrobianos de cepas de Neisseria meningitidis aisladas en portadores]]></article-title>
<source><![CDATA[VacciMonitor]]></source>
<year>2000</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>7-13</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blondeau]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ashton]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Isaacson]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ducasse]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neisseria meningitidis with decreaaased susceptibility to penicillin in Saskatchewan,Canada]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1995</year>
<volume>33</volume>
<page-range>1784-1786</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palmeiro]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Almiron]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Regueira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de sero/subtipos de Neisseria meningitidis en Argentina entre 1994-1995]]></source>
<year>1996</year>
<conf-name><![CDATA[XIII Congreso Latinoamericano de Microbiología]]></conf-name>
<conf-loc>Buenos aires </conf-loc>
<page-range>212-213</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaunt]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Single dose ciprofloxacin for the erradication of pharyngeal carriage of Neisseria meningitidis]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>1988</year>
<volume>21</volume>
<page-range>489-496</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
